IIGF-1/I Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis

Stem cell therapy stands out as a promising avenue for addressing arthritis treatment. However, its therapeutic efficacy requires further enhancement. In this study, we investigated the anti-arthritogenic potential of human amniotic mesenchymal stem cells (AMM) overexpressing insulin-like growth fac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2024-04, Vol.25 (8)
Hauptverfasser: Chae, Dong-Sik, Han, Seongho, Kim, Sung-Whan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 8
container_start_page
container_title International journal of molecular sciences
container_volume 25
creator Chae, Dong-Sik
Han, Seongho
Kim, Sung-Whan
description Stem cell therapy stands out as a promising avenue for addressing arthritis treatment. However, its therapeutic efficacy requires further enhancement. In this study, we investigated the anti-arthritogenic potential of human amniotic mesenchymal stem cells (AMM) overexpressing insulin-like growth factor 1 (IGF-1) in a collagen-induced mouse model. The IGF-1 gene was introduced into the genome of AMM through transcription activator-like effector nucleases (TALENs). We assessed the in vitro immunomodulatory properties and in vivo anti-arthritogenic effects of IGF-1-overexpressing AMM (AMM/I). Co-culture of AMM/I with interleukin (IL)-1β-treated synovial fibroblasts significantly suppressed NF-kB levels. Transplantation of AMM/I into mice with collagen-induced arthritis (CIA) led to significant attenuation of CIA progression. Furthermore, AMM/I administration resulted in the expansion of regulatory T-cell populations and suppression of T-helper-17 cell activation in CIA mice. In addition, AMM/I transplantation led to an increase in proteoglycan expression within cartilage and reduced infiltration by inflammatory cells and also levels of pro-inflammatory factors including cyclooxygenase-2 (COX-2), IL-1β, NF-kB, and tumor necrosis factor (TNF)-α. In conclusion, our findings suggest that IGF-1 gene-edited human AMM represent a novel alternative therapeutic strategy for the treatment of arthritis.
doi_str_mv 10.3390/ijms25084442
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A793550039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A793550039</galeid><sourcerecordid>A793550039</sourcerecordid><originalsourceid>FETCH-LOGICAL-g679-a758dfacba286238205d607ea8a2750cb8ebc1e8d048ee553ce0003a5a22b2c33</originalsourceid><addsrcrecordid>eNptjD1rwzAURTW00DTt1h8g6KxElixbHo3JhyGl0GYPsvTsvGDLYCnQ_vsamqFDucOFy7mHkJeEr6Qs-BovQxCK6zRNxR1ZJKkQjPMsfyCPIVw4F1KoYkFcXe-2LFnXdAd-HIBtHEZwdH8djKdvn1Wgm68zNhjpx9hcQ6Slj8jKKZ4njGMHHi3Gb4qeVmPfm3lgtXdXOztuEIYnct-aPsDzrZfkuN0cqz07vO_qqjywLssLZnKlXWtsY4TOhNSCK5fxHIw2IlfcNhoam4B2PNUASkkLnHNplBGiEVbKJXn91XamhxP6doyTsQMGeyrzQio108VMrf6h5jgY0I4eWpz3P4cfzhRkRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>IIGF-1/I Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Chae, Dong-Sik ; Han, Seongho ; Kim, Sung-Whan</creator><creatorcontrib>Chae, Dong-Sik ; Han, Seongho ; Kim, Sung-Whan</creatorcontrib><description>Stem cell therapy stands out as a promising avenue for addressing arthritis treatment. However, its therapeutic efficacy requires further enhancement. In this study, we investigated the anti-arthritogenic potential of human amniotic mesenchymal stem cells (AMM) overexpressing insulin-like growth factor 1 (IGF-1) in a collagen-induced mouse model. The IGF-1 gene was introduced into the genome of AMM through transcription activator-like effector nucleases (TALENs). We assessed the in vitro immunomodulatory properties and in vivo anti-arthritogenic effects of IGF-1-overexpressing AMM (AMM/I). Co-culture of AMM/I with interleukin (IL)-1β-treated synovial fibroblasts significantly suppressed NF-kB levels. Transplantation of AMM/I into mice with collagen-induced arthritis (CIA) led to significant attenuation of CIA progression. Furthermore, AMM/I administration resulted in the expansion of regulatory T-cell populations and suppression of T-helper-17 cell activation in CIA mice. In addition, AMM/I transplantation led to an increase in proteoglycan expression within cartilage and reduced infiltration by inflammatory cells and also levels of pro-inflammatory factors including cyclooxygenase-2 (COX-2), IL-1β, NF-kB, and tumor necrosis factor (TNF)-α. In conclusion, our findings suggest that IGF-1 gene-edited human AMM represent a novel alternative therapeutic strategy for the treatment of arthritis.</description><identifier>ISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25084442</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Analysis ; Antiarthritic agents ; Arthritis ; Collagen ; Genes ; Genetic aspects ; Genetic transcription ; Genomes ; Genomics ; Health aspects ; Interleukins ; Stem cells ; T cells ; Transplantation</subject><ispartof>International journal of molecular sciences, 2024-04, Vol.25 (8)</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Chae, Dong-Sik</creatorcontrib><creatorcontrib>Han, Seongho</creatorcontrib><creatorcontrib>Kim, Sung-Whan</creatorcontrib><title>IIGF-1/I Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis</title><title>International journal of molecular sciences</title><description>Stem cell therapy stands out as a promising avenue for addressing arthritis treatment. However, its therapeutic efficacy requires further enhancement. In this study, we investigated the anti-arthritogenic potential of human amniotic mesenchymal stem cells (AMM) overexpressing insulin-like growth factor 1 (IGF-1) in a collagen-induced mouse model. The IGF-1 gene was introduced into the genome of AMM through transcription activator-like effector nucleases (TALENs). We assessed the in vitro immunomodulatory properties and in vivo anti-arthritogenic effects of IGF-1-overexpressing AMM (AMM/I). Co-culture of AMM/I with interleukin (IL)-1β-treated synovial fibroblasts significantly suppressed NF-kB levels. Transplantation of AMM/I into mice with collagen-induced arthritis (CIA) led to significant attenuation of CIA progression. Furthermore, AMM/I administration resulted in the expansion of regulatory T-cell populations and suppression of T-helper-17 cell activation in CIA mice. In addition, AMM/I transplantation led to an increase in proteoglycan expression within cartilage and reduced infiltration by inflammatory cells and also levels of pro-inflammatory factors including cyclooxygenase-2 (COX-2), IL-1β, NF-kB, and tumor necrosis factor (TNF)-α. In conclusion, our findings suggest that IGF-1 gene-edited human AMM represent a novel alternative therapeutic strategy for the treatment of arthritis.</description><subject>Analysis</subject><subject>Antiarthritic agents</subject><subject>Arthritis</subject><subject>Collagen</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genetic transcription</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Health aspects</subject><subject>Interleukins</subject><subject>Stem cells</subject><subject>T cells</subject><subject>Transplantation</subject><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjD1rwzAURTW00DTt1h8g6KxElixbHo3JhyGl0GYPsvTsvGDLYCnQ_vsamqFDucOFy7mHkJeEr6Qs-BovQxCK6zRNxR1ZJKkQjPMsfyCPIVw4F1KoYkFcXe-2LFnXdAd-HIBtHEZwdH8djKdvn1Wgm68zNhjpx9hcQ6Slj8jKKZ4njGMHHi3Gb4qeVmPfm3lgtXdXOztuEIYnct-aPsDzrZfkuN0cqz07vO_qqjywLssLZnKlXWtsY4TOhNSCK5fxHIw2IlfcNhoam4B2PNUASkkLnHNplBGiEVbKJXn91XamhxP6doyTsQMGeyrzQio108VMrf6h5jgY0I4eWpz3P4cfzhRkRA</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Chae, Dong-Sik</creator><creator>Han, Seongho</creator><creator>Kim, Sung-Whan</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20240401</creationdate><title>IIGF-1/I Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis</title><author>Chae, Dong-Sik ; Han, Seongho ; Kim, Sung-Whan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g679-a758dfacba286238205d607ea8a2750cb8ebc1e8d048ee553ce0003a5a22b2c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Antiarthritic agents</topic><topic>Arthritis</topic><topic>Collagen</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genetic transcription</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Health aspects</topic><topic>Interleukins</topic><topic>Stem cells</topic><topic>T cells</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chae, Dong-Sik</creatorcontrib><creatorcontrib>Han, Seongho</creatorcontrib><creatorcontrib>Kim, Sung-Whan</creatorcontrib><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chae, Dong-Sik</au><au>Han, Seongho</au><au>Kim, Sung-Whan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IIGF-1/I Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis</atitle><jtitle>International journal of molecular sciences</jtitle><date>2024-04-01</date><risdate>2024</risdate><volume>25</volume><issue>8</issue><issn>1422-0067</issn><abstract>Stem cell therapy stands out as a promising avenue for addressing arthritis treatment. However, its therapeutic efficacy requires further enhancement. In this study, we investigated the anti-arthritogenic potential of human amniotic mesenchymal stem cells (AMM) overexpressing insulin-like growth factor 1 (IGF-1) in a collagen-induced mouse model. The IGF-1 gene was introduced into the genome of AMM through transcription activator-like effector nucleases (TALENs). We assessed the in vitro immunomodulatory properties and in vivo anti-arthritogenic effects of IGF-1-overexpressing AMM (AMM/I). Co-culture of AMM/I with interleukin (IL)-1β-treated synovial fibroblasts significantly suppressed NF-kB levels. Transplantation of AMM/I into mice with collagen-induced arthritis (CIA) led to significant attenuation of CIA progression. Furthermore, AMM/I administration resulted in the expansion of regulatory T-cell populations and suppression of T-helper-17 cell activation in CIA mice. In addition, AMM/I transplantation led to an increase in proteoglycan expression within cartilage and reduced infiltration by inflammatory cells and also levels of pro-inflammatory factors including cyclooxygenase-2 (COX-2), IL-1β, NF-kB, and tumor necrosis factor (TNF)-α. In conclusion, our findings suggest that IGF-1 gene-edited human AMM represent a novel alternative therapeutic strategy for the treatment of arthritis.</abstract><pub>MDPI AG</pub><doi>10.3390/ijms25084442</doi></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2024-04, Vol.25 (8)
issn 1422-0067
language eng
recordid cdi_gale_infotracmisc_A793550039
source MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Analysis
Antiarthritic agents
Arthritis
Collagen
Genes
Genetic aspects
Genetic transcription
Genomes
Genomics
Health aspects
Interleukins
Stem cells
T cells
Transplantation
title IIGF-1/I Genome-Edited Human MSCs Exhibit Robust Anti-Arthritogenicity in Collagen-Induced Arthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A55%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IIGF-1/I%20Genome-Edited%20Human%20MSCs%20Exhibit%20Robust%20Anti-Arthritogenicity%20in%20Collagen-Induced%20Arthritis&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Chae,%20Dong-Sik&rft.date=2024-04-01&rft.volume=25&rft.issue=8&rft.issn=1422-0067&rft_id=info:doi/10.3390/ijms25084442&rft_dat=%3Cgale%3EA793550039%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A793550039&rfr_iscdi=true